ADC Therapeutics

About:

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Website: http://www.adctherapeutics.com

Twitter/X: adctherapeutics

Top Investors: Deerfield, AstraZeneca, Redmile Group, MedImmune, 4BIO Capital

Description:

ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Their ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer technology providing a superior therapeutic index compared to first-generation PBD ADCs in preclinical studies. PBD dimers are very potent toxins that actively kill cancer cells and have a differentiated mechanism of action than warheads commonly used in other ADCs.